Close Menu

NEW YORK (GenomeWeb) – China's BGI said this week that it has received a CLIA certificate of registration for its Hong Kong laboratory.

BGI said the certification will help it to expand its offering of clinical sequencing services for specific diseases, including cancer and Mendelian disorders. It will also be useful for genomics-based clinical trial testing as part of BGI's CRO pharma solutions, which support drug discovery and development for biopharmaceutical clients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.